A Novel Y-Shaped Pegylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency.

J Clin Endocrinol Metab · 2025 · PMC12261095 · PMID 39607675

Europe PMC DOI

hedged sentence

0.2590

closest p · 5.2× alpha

0.2590

boldest claim

The sentences

a decreasing trendP = .259not close (p > 0.1)

Additionally, Ht SDS BA in both treatment groups exhibited a decreasing trend compared to baseline, without statistically significant changes ( P = .259 and 0.138, respectively), suggesting that neither Pegpesen nor daily rhGH significantly accelerated BA growth or induced premature epiphyseal closure.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.